Concepedia

Michael Cremin

MC

Statistics

Publications

5

Citations

75

H-Index

5

Active since

2019

Affiliations

University of California, Davis(Current)

Michael Cremin is an author at University of California, Davis specializing in oncology, cancer immunotherapy, and t cell responses to tumors.

ORCID

Publications per year

2019–2025

5

Publications

5

HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors

Mary E. Molloy, Wade H. Aaron, Manasi Barath et al. · Molecular Cancer Therapeutics · 2024 · 29 citations · Full text

, , +17

Abstract C033: HPN328: An anti-DLL3 T cell engager for treatment of small cell lung cancer

Wade H. Aaron, Richard J. Austin, Manasi Barath et al. · Molecular Cancer Therapeutics · 2019 · 14 citations

, , +12

Substance P receptor signaling contributes to host maladaptive responses during enteric bacterial infection

Michael Cremin, Valerie T. Ramírez, Kristina Sanchez et al. · Proceedings of the National Academy of Sciences · 2025 · 11 citations · Full text

, , +17

Inhibition of acute lung inflammation by a neuroimmune circuit induced by vagal nerve stimulation

Kaitlin Murray, Michael Cremin, Emmy Xue Yun Tay et al. · Science Advances · 2025 · 11 citations · Full text

, , +17

TRPV1 controls innate immunity during Citrobacter rodentium enteric infection

Michael Cremin, Emmy Xue Yun Tay, Valerie T. Ramírez et al. · PLoS Pathogens · 2023 · 10 citations · Full text

, , +16

1–5 of 5